Back to Search
Start Over
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
- Source :
-
Molecular diagnosis & therapy [Mol Diagn Ther] 2023 Mar; Vol. 27 (2), pp. 281. Date of Electronic Publication: 2023 Mar 04. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1179-2000
- Volume :
- 27
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Molecular diagnosis & therapy
- Accession number :
- 36870041
- Full Text :
- https://doi.org/10.1007/s40291-023-00643-4